Low Expression of the E3 Ubiquitin Ligase CBL Confers Chemoresistance in Human Pancreatic Cancer and Is Targeted by Epidermal Growth Factor Receptor Inhibition
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-0610
Full Text
Open PDFAbstract
Available in full text
Date
October 27, 2014
Authors
Publisher
American Association for Cancer Research (AACR)